The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3,4-dichlorobenzyl)-4-fluoro-5-hydroxy-1H-indole-2-carboxylic acid ID: ALA4092536
PubChem CID: 9928514
Max Phase: Preclinical
Molecular Formula: C16H10Cl2FNO3
Molecular Weight: 354.16
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1cc2c(F)c(O)ccc2n1Cc1ccc(Cl)c(Cl)c1
Standard InChI: InChI=1S/C16H10Cl2FNO3/c17-10-2-1-8(5-11(10)18)7-20-12-3-4-14(21)15(19)9(12)6-13(20)16(22)23/h1-6,21H,7H2,(H,22,23)
Standard InChI Key: XVJRJCHFAPOINJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
24.1068 -7.2206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5553 -6.6068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8113 -5.8228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2556 -5.2090 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
24.6148 -5.6526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8708 -4.8686 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
25.1664 -6.2622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9102 -7.0504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4660 -7.6601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2100 -8.4441 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.4259 -8.7002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7130 -8.2856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9961 -8.7002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9961 -9.5252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2831 -9.9356 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.7130 -9.9356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7130 -10.7607 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.4259 -9.5252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2100 -9.7812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6947 -9.1106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5198 -9.1105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9303 -8.3977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9303 -9.8234 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
3 5 1 0
5 6 1 0
5 7 2 0
7 8 1 0
1 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
14 16 2 0
16 17 1 0
16 18 1 0
11 18 2 0
18 19 1 0
19 20 2 0
10 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 354.16Molecular Weight (Monoisotopic): 353.0022AlogP: 4.54#Rotatable Bonds: 3Polar Surface Area: 62.46Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.39CX Basic pKa: ┄CX LogP: 4.64CX LogD: 1.11Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.73Np Likeness Score: -1.17
References 1. Warner DJ, Chen H, Cantin LD, Kenna JG, Stahl S, Walker CL, Noeske T.. (2012) Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification., 40 (12): [PMID:22961681 ] [10.1124/dmd.112.047068 ]